Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.47 |
| ▸ | TSHR | P16473 | 3/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.42 |
| ▸ | AHR | P35869 | 1/20 | 0.40 |
| ▸ | IDO1 | P14902 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31143401 | 1.00 | ALDH1A1 (0.47) | ALDH1A1TDP1TSHRGAAHTT | |
| SCHEMBL7409028 | 0.90 | ALDH1A1 (0.45) | ALDH1A1TDP1TSHRGAAHTT | |
| SCHEMBL15545142 | 0.82 | ALDH1A1 (0.42) | ALDH1A1TDP1TSHRGAAHTT | |
| SCHEMBL15545143 | 0.82 | ALDH1A1 (0.42) | ALDH1A1TDP1TSHRGAAHTT | |
| SCHEMBL29606539 | 0.80 | ALDH1A1 (0.50) | ALDH1A1TDP1TSHRGAAHTT | |
| SCHEMBL29438693 | 0.80 | ALDH1A1 (0.54) | ALDH1A1TDP1GAAHTTMEN1 | |
| SCHEMBL364459 | 0.80 | ALDH1A1 (0.54) | ALDH1A1TDP1GAAHTTMEN1 | |
| SCHEMBL3942261 | 0.80 | ALDH1A1 (0.50) | ALDH1A1TDP1TSHRGAAHTT | |
| SCHEMBL29780392 | 0.78 | AHR (0.51) | ALDH1A1TDP1TSHRHTTMEN1 | |
| SCHEMBL985995 | 0.78 | AHR (0.51) | ALDH1A1TDP1TSHRHTTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 595 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115433121-B | Synthetic method of aliphatic diamine monomer for preparing transparent polyimide | 东南大学 | 2023-11-28 | — | — | CN | claimed |
| CN-115433121-A | Synthetic method of aliphatic diamine monomer for preparing transparent polyimide | 东南大学 | 2022-12-06 | — | — | CN | claimed |
| CN-112142654-A | Aromatic diamine monomer containing fluorene group and pyridine heterocyclic structure and preparation method and application thereof | 东华大学 | 2020-12-29 | — | — | CN | claimed |
| CN-108299387-B | Method for preparing mirtazapine impurity K | 心邀（深圳）生物科技有限公司 | 2020-11-17 | — | — | CN | claimed |
| CN-105541703-A | Triamine monomer containing pyridine structure and preparation method thereof | UNIV JILIN | 2016-05-04 | — | — | CN | claimed |
| EP-4731206-A2 | COMPOSITIONS AND METHODS OF USE TO TREAT 12-LIPOXYGENASE (12-LOX) MEDIATED DISEASES | Veralox Therapeutics Inc. (US) | 2026-04-29 | — | — | EP | disclosed |
| US-20260085073-A1 | PYRAZOLYLCARBOXAMIDE COMPOUNDS AND THEIR USE IN THERAPY | HOTSPOT THERAPEUTICS INC (US) | 2026-03-26 | — | — | US | disclosed |
| US-20260078091-A1 | Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer | AMGEN INC (US) | 2026-03-19 | — | — | US | disclosed |
| US-20260078122-A1 | INDAZOLE COMPOUNDS AS PKMYT1 KINASE INHIBITORS | HOFFMANN-LA ROCHE INC. (US) | 2026-03-19 | — | — | US | disclosed |
| US-20260049085-A1 | CYCLIC COMPOUNDS AND METHODS OF USING SAME | SCHRÖDINGER, INC. (US) | 2026-02-19 | — | — | US | disclosed |
| EP-4673436-A1 | INDAZOLE COMPOUNDS AS PKMYT1 KINASE INHIBITORS | F. Hoffmann-La Roche AG (CH) | 2026-01-07 | — | — | EP | disclosed |
| EP-4637925-A1 | INHIBITORS OF ALPHA-HEMOLYSIN OF STAPHYLOCOCCUS AUREUS | Helmholtz-Zentrum für Infektionsforschung GmbH (DE) | 2025-10-29 | — | — | EP | disclosed |
| US-4540578-A | Pesticidal phenoxypyridyl benzoyl ureas | UNION CARBIDE CORPORATION (US) | 1985-09-10 | — | — | US | disclosed |
| EP-0046735-B1 | PROCESS FOR THE PREPARATION OF CHLOROPYRIDINES SUBSTITUTED WITH METHYL OR TRIFLUOROMETHYL GROUPS | CIBA-GEIGY AG (CH) | 1984-12-12 | — | — | EP | disclosed |
| US-4486434-A | PYRIDYLALKYLAMINO PYRIDYLMETHYL PYRIMIDONES | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1984-12-04 | — | — | US | disclosed |
| US-4469896-A | Process for the production of chloropyridines substituted by methyl, trichloromethyl or trifluoromethyl groups | CIBA-GEIGY CORPORATION (US) | 1984-09-04 | — | — | US | disclosed |
| EP-0113247-A1 | Pesticidal phenoxyphenyl and phenoxypyridyl benzoyl ureas and process for their preparation | UNION CARBIDE CORPORATION (US) | 1984-07-11 | — | — | EP | disclosed |
| EP-0112707-A2 | Aminopyrimidinone derivatives as histamine H1-antagonists | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1984-07-04 | — | — | EP | disclosed |
| EP-0068833-A2 | Pyrimidinone derivatives and pharmaceutical compositions containing them | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1983-01-05 | — | — | EP | disclosed |
| EP-0046735-A2 | Process for the preparation of chloropyridines substituted with methyl or trifluoromethyl groups | CIBA-GEIGY AG (CH) | 1982-03-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260078122-A1 | INDAZOLE COMPOUNDS AS PKMYT1 KINASE INHIBITORS | PKN3, PKMYT1, IP6K3 | ALDH1A1 3032/4885TDP1 1527/4885TSHR 2477/4885 |
| US-20260078091-A1 | Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer | TP53, HIF1AN, MDM2 | ALDH1A1 821/4885TDP1 433/4885TSHR 4574/4885 |
| US-20260049085-A1 | CYCLIC COMPOUNDS AND METHODS OF USING SAME | CCR1, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, MALT1 | ALDH1A1 2214/4885TDP1 3708/4885TSHR 158/4885 |
| US-20260085073-A1 | PYRAZOLYLCARBOXAMIDE COMPOUNDS AND THEIR USE IN THERAPY | MALT1, BCL6, BCL3 | ALDH1A1 2586/4885TDP1 2187/4885TSHR 2143/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.